UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040951
Receipt number R000046731
Scientific Title A study of effect and adherence of miconazole oral tablets for oral candidiasis
Date of disclosure of the study information 2020/07/10
Last modified on 2020/06/29 22:01:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of effect and adherence of miconazole oral tablets for oral candidiasis

Acronym

A study of effect and adherence of miconazole oral tablets

Scientific Title

A study of effect and adherence of miconazole oral tablets for oral candidiasis

Scientific Title:Acronym

A study of effect and adherence of miconazole oral tablets

Region

Japan


Condition

Condition

oral candidiasis

Classification by specialty

Oral surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the clinical efficacy and adherence to medication of miconazole oral mucoadhesive tablet (Orabi) 50 mg, a synthetic imidazole antifungal drug with broad spectrum.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Treatment success rate on Day 14

Key secondary outcomes

Confirmation of side effects due to oral use of Orabi tablets


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Oravi 50mg once a day for 14 days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Candida positive in culture test

Key exclusion criteria

Pregnant or breastfeeding
Milk allergy
Administration of antifungal drugs within 14 days

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Eiji
Middle name
Last name Kondo

Organization

Shinshu University School of Medicine

Division name

Department of Dentistry and Oral Surgery

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto, Japan

TEL

0263-37-2677

Email

eiji@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Eiji
Middle name
Last name Kondo

Organization

Shinshu University School of Medicine

Division name

Department of Dentistry and Oral Surgery

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto, Japan

TEL

0263-37-2677

Homepage URL


Email

eiji@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University School of Medicine, Department of Dentistry and Oral Surgery

Institute

Department

Personal name



Funding Source

Organization

Shinshu University School of Medicine, Department of Dentistry and Oral Surgery

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

MINAMINAGANO MEDICAL CENTER SHINONOI GENERAL HOSPITAL

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University School of Medicine, Department of Dentistry and Oral Surgery

Address

3-1-1 Asahi, Matsumoto, Japan

Tel

0263-37-2677

Email

eiji@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2020 Year 07 Month 10 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 29 Day

Last modified on

2020 Year 06 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046731


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name